Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Intellia Therapeutics (NTLA) Total Current Liabilities (2016 - 2025)

Historic Total Current Liabilities for Intellia Therapeutics (NTLA) over the last 11 years, with Q3 2025 value amounting to $93.7 million.

  • Intellia Therapeutics' Total Current Liabilities fell 1131.4% to $93.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $93.7 million, marking a year-over-year decrease of 1131.4%. This contributed to the annual value of $110.9 million for FY2024, which is 378.19% down from last year.
  • According to the latest figures from Q3 2025, Intellia Therapeutics' Total Current Liabilities is $93.7 million, which was down 1131.4% from $95.5 million recorded in Q2 2025.
  • Over the past 5 years, Intellia Therapeutics' Total Current Liabilities peaked at $131.1 million during Q3 2022, and registered a low of $60.7 million during Q1 2021.
  • Over the past 5 years, Intellia Therapeutics' median Total Current Liabilities value was $105.1 million (recorded in 2024), while the average stood at $105.1 million.
  • Per our database at Business Quant, Intellia Therapeutics' Total Current Liabilities surged by 10775.43% in 2022 and then crashed by 2987.75% in 2023.
  • Quarter analysis of 5 years shows Intellia Therapeutics' Total Current Liabilities stood at $125.8 million in 2021, then grew by 0.57% to $126.6 million in 2022, then fell by 8.97% to $115.2 million in 2023, then decreased by 3.78% to $110.9 million in 2024, then dropped by 15.45% to $93.7 million in 2025.
  • Its Total Current Liabilities stands at $93.7 million for Q3 2025, versus $95.5 million for Q2 2025 and $112.6 million for Q1 2025.